drugset / Trial / NCT00334802
Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To investigate efficacy, safety and PK of gemcitabine and paclitaxel combination in patients with metastatic breast cancer after adjuvant/neo-adjuvant chemotherapy with anthracycline regimen
Timeline
- Start
- 2006-06
- Primary completion
- 2008-02
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 175 mg/m2 | Intravenous |